Elizabeth Douville - Profile and Investment Details

Investor Profile

Elizabeth Douville is a Venture Capital, Founder, Investor based in Montréal, Quebec, Canada with a diverse investment portfolio that includes companies such as Salmedix Inc, Semathera, MethylGene, Corbin Therapeutics Inc, Copernicus Therapeutics, Cytochroma, NewBiotics, SemaThera Inc, Ceptyr, Elitra Pharmaceuticals, Novalon Pharmaceutical, BIOQuebec, Message Pharmaceuticals, LymphoSign, GeneFormaticsGene Logic, Ambit Biosciences, The Medicines Company, Xanthus Pharmaceuticals, Osprey Pharmaceuticals USA, BioCanRx, Inversago Pharma, Aegera Therapeutics, Interomex BioPharmaceuticals, Genome Canada, Viron Therapeutics, Centre de production de produits biologiques (CPPB) inc. / Biologics Manufacturing Centre (BMC) Inc., Lexicon Pharmaceuticals, . Over time, Elizabeth Douville has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Elizabeth Douville is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Creative Venture, Intellectual Asset Management, Health Care, Drug Discovery, Wellness, Immunotherapy, Rare Diseases, Strategic Partnerships, Life Science, Engineering, Portfolio Management, Biotechnology, Drug Development, Clinical Trials, Research, Licensing, Technology Transfer, Medical, B2B, Therapeutics, Pharmaceuticals, Oncology may find it worthwhile to explore potential connections with Elizabeth Douville, as their portfolio suggests a familiarity and interest in this area.

Understanding Elizabeth Douville’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.